| Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring NJ Ashton, S Janelidze, N Mattsson-Carlgren, AP Binette, O Strandberg, ... Nature medicine 28 (12), 2555-2562, 2022 | 245 | 2022 |
| Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology NJ Ashton, WS Brum, G Di Molfetta, AL Benedet, B Arslan, E Jonaitis, ... JAMA neurology 81 (3), 255-263, 2024 | 211 | 2024 |
| Levels of Alzheimer's disease blood biomarkers are altered after food intake—A pilot intervention study in healthy adults H Huber, NJ Ashton, A Schieren, L Montoliu‐Gaya, GD Molfetta, WS Brum, ... Alzheimer's & Dementia 19 (12), 5531-5540, 2023 | 24 | 2023 |
| Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology J Therriault, NJ Ashton, I Pola, G Triana-Baltzer, WS Brum, G Di Molfetta, ... EBioMedicine 102, 2024 | 22 | 2024 |
| Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer’s disease pathology NJ Ashton, WS Brum, G Di Molfetta, AL Benedet, B Arslan, E Jonatis, ... medRxiv, 2023 | 19 | 2023 |
| Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic M Bucci, M Bluma, I Savitcheva, NJ Ashton, K Chiotis, A Matton, ... Translational Psychiatry 13 (1), 268, 2023 | 11 | 2023 |
| Longitudinal plasma phosphorylated‐tau217 and other related biomarkers in a non‐demented Alzheimer's risk‐enhanced sample L Du, RE Langhough, RE Wilson, RER Reyes, BP Hermann, EM Jonaitis, ... Alzheimer's & Dementia 20 (9), 6183-6204, 2024 | 5 | 2024 |
| Blood β‐synuclein is related to amyloid PET positivity in memory clinic patients P Oeckl, M Bluma, M Bucci, S Halbgebauer, K Chiotis, ... Alzheimer's & Dementia 19 (11), 4896-4907, 2023 | 4 | 2023 |
| Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid-PET S De Meyer, JM Schaeverbeke, ES Luckett, M Reinartz, ER Blujdea, ... Brain Communications, fcae162, 2024 | 2 | 2024 |
| Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects F Martínez-Dubarbie, S López-García, C Lage, G Di Molfetta, ... Journal of Alzheimer's Disease, 1-14, 2024 | 2 | 2024 |
| Plasma pTau217: single vs multiple phospho‐site assays. AL Benedet, I Pola, G Triana‐Baltzer, GD Molfetta, B Arslan, N Rahmouni, ... Alzheimer's & Dementia 19, e082953, 2023 | 2 | 2023 |
| Biomarker Discovery in Alzheimer’s and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich Assay NJ Ashton, AL Benedet, G Di Molfetta, I Pola, F Anastasi, ... medRxiv, 2024.07. 29.24311079, 2024 | 1 | 2024 |
| Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease NJ Ashton, G Di Molfetta, K Tan, K Blennow, H Zetterberg, A Messing Neurological Sciences, 1-6, 2024 | 1 | 2024 |
| Understanding the variability in plasma biomarker levels in the context of established biomarkers of Alzheimer’s disease M Bluma, K Chiotis, M Bucci, I Savitcheva, A Matton, M Kivipelto, ... Alzheimer's & Dementia 20 (Suppl 2), e090702, 2025 | | 2025 |
| Inflammation biomarkers and Alzheimer's disease: A pilot study using NULISAseq G Di Molfetta, I Pola, K Tan, R Isaacson, K Blennow, NJ Ashton, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 17 (1 …, 2025 | | 2025 |
| Identify biological Alzheimer’s disease using a novel nucleic acid–linked protein immunoassay YT Wang, NJ Ashton, J Therriault, AL Benedet, AC Macedo, I Pola, ... Brain Communications 7 (1), fcaf004, 2025 | | 2025 |
| Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics M Bluma, K Chiotis, M Bucci, I Savitcheva, A Matton, M Kivipelto, ... EBioMedicine, 2024 | | 2024 |
| Validation of the plasma phosphorylated tau quantified using NUcleic acid Linked Immuno‐Sandwich Assay (NULISA) for the detection of Alzheimer’s disease pathology YT Wang, NJ Ashton, J Therriault, AL Benedet, AC Macedo, I Pola, ... Alzheimer's & Dementia 20, e094671, 2024 | | 2024 |
| Plasma proteomic profiling of mild cognitive impairment in two cohorts using the NULISAseq CNS Disease panel GD Molfetta, AL Benedet, B Zhang, N Rahmouni, S Servaes, J Stevenson, ... Alzheimer's & Dementia 20, e092364, 2024 | | 2024 |
| Plasma proteomic changes in carriers of progranulin mutations on the novel NULISA platform J Simrén, AL Benedet, B Zhang, GD Molfetta, V Cantoni, I Libri, J Rivolta, ... Alzheimer's & Dementia 20, e092348, 2024 | | 2024 |
